View of Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory Inflammatory TNFα – IL-23 – IL-17 Axis

Return to Article Details Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory Inflammatory TNFα – IL-23 – IL-17 Axis Download Download PDF